Generated by GPT-5-mini| Nitroglycerin | |
|---|---|
![]() BartVL71 · Public domain · source | |
| Name | Nitroglycerin |
| Iupac name | 1,2,3-trinitroxypropane |
| Other names | Glyceryl trinitrate |
| Cas number | 55-63-0 |
| Formula | C3H5N3O9 |
| Molar mass | 227.09 g·mol−1 |
| Density | 1.60 g·cm−3 |
| Appearance | Colorless, oily liquid |
Nitroglycerin is an organic nitrate ester historically important as both an explosive and a cardiovascular drug. Discovered in the 19th century, it links to developments in Chemical industry, Industrial Revolution, and Cardiology. Its dual role influenced figures such as Alfred Nobel, institutions like explosives works, and events including the Second Industrial Revolution.
The discovery of nitroglycerin occurred amid 19th-century chemical experimentation involving figures like Ascanio Sobrero and contemporaries in Turin and Paris. The compound's explosive potential prompted practical work by Alfred Nobel, whose development of stable blasting agents and the founding of the Nobel Prize legacy tied nitroglycerin to industrial entrepreneurs and inventors associated with Bofors and other firms. Accidents at early plants influenced policy responses by states such as United Kingdom and Sweden, and catalyzed engineering advances adopted in projects like the Suez Canal and the expansion of railways.
Nitroglycerin is chemically a nitrate ester of glycerol with three nitrooxy groups; its structure gives rise to high oxygen content and sensitivity. Laboratory preparation historically follows nitration of glycerol with mixed acids involving nitric acid and sulfuric acid, a process paralleling classical methods used in organic chemistry laboratories and by industrial manufacturers such as Dynamit Nobel. Physical constants—molar mass, density, and boiling point—reflect its energetics, while thermal decomposition pathways relate to energetic materials theory explored by researchers at institutions like Lawrence Livermore National Laboratory and Los Alamos National Laboratory. Modern synthesis and purification techniques draw on protocols from petrochemical firms and safety standards promulgated by agencies such as United States Environmental Protection Agency and European Chemicals Agency.
In cardiovascular medicine, nitroglycerin acts via enzymatic biotransformation to release nitric oxide, interfacing with biochemical pathways identified by researchers at Nobel Assembly at Karolinska Institutet and laboratories affiliated with Harvard Medical School and Johns Hopkins University. Nitric oxide activates guanylate cyclase and increases cyclic guanosine monophosphate, mechanisms elucidated in foundational work tied to recipients of the Nobel Prize in Physiology or Medicine. These signaling events produce vascular smooth muscle relaxation, outcomes studied in clinical settings at centers like Mayo Clinic and Cleveland Clinic and modeled in cardiovascular research at universities including Stanford University and University of Oxford.
Clinically, nitroglycerin is used for relief of angina pectoris and management of acute coronary syndromes, practices standardized in guidelines from organizations such as the American Heart Association and the European Society of Cardiology. Formulations include sublingual tablets, transdermal patches, topical ointments, and intravenous infusions deployed in hospitals like Massachusetts General Hospital and Royal Brompton Hospital. Combination therapies often reference pharmacology taught at institutions like Columbia University and University of California, San Francisco. Historical therapeutic adoption involved practitioners at hospitals named after benefactors and administrators from entities like Johns Hopkins Hospital and governmental health agencies including the National Institutes of Health.
Because of extreme sensitivity to shock and heat, safe handling of nitroglycerin in manufacturing contexts has been shaped by industrial safety frameworks from Occupational Safety and Health Administration and accident investigations by agencies such as Federal Emergency Management Agency. Toxicity manifests as headache, hypotension, and methemoglobinemia at high exposures; clinical toxicology is managed in emergency departments at centers like Royal Infirmary of Edinburgh and referenced in guidelines from World Health Organization. Historical workplace incidents influenced labor reforms and standards promulgated by organizations such as the International Labour Organization and standards bodies like ISO.
Beyond medical use, nitroglycerin is a component of dynamite and propellants developed by industrialists and companies like Nobel Industries and successors in the explosives industry. Its manufacture, storage, and transportation are regulated by national authorities such as the United States Department of Transportation and international agreements including conventions overseen by United Nations bodies. Applications spanned mining projects like those of Rio Tinto Group, construction works associated with Panama Canal endeavors, and military uses legislated by treaties and reviewed in studies at Stockholm International Peace Research Institute. Contemporary regulation balances civilian medical use, industrial necessity, and public safety with oversight from agencies including Food and Drug Administration and European Medicines Agency.
Category:Nitrate esters